Variant report

Variant	esv3377185
Chromosome Location	chr5:177365371-177368219
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:59)
CpG islands
(count:244)
Chromatin interactive
region (count:1)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:59 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CBX3	chr5:177368192-177368988	K562	blood:	n/a	n/a
2	CEBPD	chr5:177368178-177368824	K562	blood:	n/a	n/a
3	CTCF	chr5:177366524-177366680	MCF-7	breast:	n/a	n/a
4	CTCF	chr5:177366732-177366766	GM13976	blood:	n/a	n/a
5	CTCF	chr5:177366683-177366730	Fibrobl	skin:	n/a	n/a
6	CTCF	chr5:177366682-177366683	MCF-7	breast:	n/a	n/a
7	CTCF	chr5:177366700-177366772	Spleen_OC	spleen:	n/a	n/a
8	CTCF	chr5:177366696-177366770	NHEK	skin:	n/a	n/a
9	CTCF	chr5:177366295-177366362	NHEK	skin:	n/a	n/a
10	CTCF	chr5:177366494-177366732	MCF-7	breast:	n/a	n/a
11	CTCF	chr5:177367770-177367796	GM13976	blood:	n/a	n/a
12	CTCF	chr5:177367726-177367757	GM13976	blood:	n/a	n/a
13	CTCF	chr5:177366288-177366372	MCF-7	breast:	n/a	n/a
14	CTCF	chr5:177366903-177366978	LNCaP	prostate:	n/a	n/a
15	CTCF	chr5:177366684-177366740	MCF-7	breast:	n/a	n/a
16	CTCF	chr5:177366896-177366946	NHEK	skin:	n/a	n/a
17	E2F4	chr5:177366519-177366581	MCF10A-Er-Src	breast:	n/a	n/a
18	GATA1	chr5:177367992-177368971	PBDE	blood:	n/a	n/a
19	GATA2	chr5:177368127-177368818	K562	blood:	n/a	n/a
20	HA-E2F1	chr5:177366104-177366708	MCF-7	breast:	n/a	n/a
21	MXI1	chr5:177366212-177366804	SK-N-SH	brain:	n/a	n/a
22	MYC	chr5:177366462-177366531	MCF-7	breast:	n/a	n/a
23	MYC	chr5:177366191-177366320	MCF-7	breast:	n/a	n/a
24	MYC	chr5:177366437-177366612	H1-hESC	embryonic stem cell:	n/a	n/a
25	MYC	chr5:177366180-177366199	MCF-7	breast:	n/a	n/a
26	MYC	chr5:177366202-177366939	MCF-7	breast:	n/a	n/a
27	MYC	chr5:177366274-177366906	MCF-7	breast:	n/a	n/a
28	MYC	chr5:177366332-177366675	MCF-7	breast:	n/a	n/a
29	MYC	chr5:177366532-177366620	MCF-7	breast:	n/a	n/a
30	NRF1	chr5:177366300-177366767	SK-N-SH	brain:	n/a	n/a
31	POLR2A	chr5:177368126-177368157	K562	blood:	n/a	n/a
32	POLR2A	chr5:177366085-177366881	MCF-7	breast:	n/a	n/a
33	POLR2A	chr5:177366374-177366688	HUVEC	blood vessel:	n/a	n/a
34	POLR2A	chr5:177366666-177366909	H1-hESC	embryonic stem cell:	n/a	n/a
35	POLR2A	chr5:177366130-177366794	Gliobla	brain:	n/a	n/a
36	POLR2A	chr5:177366249-177366757	A549	lung:	n/a	n/a
37	POLR2A	chr5:177366194-177366853	ProgFib	skin:	n/a	n/a
38	POLR2A	chr5:177366242-177366761	ECC-1	luminal epithelium:	n/a	n/a
39	POLR2A	chr5:177366153-177366888	MCF-7	breast:	n/a	n/a
40	POLR2A	chr5:177367696-177367850	H1-hESC	embryonic stem cell:	n/a	n/a
41	POLR2A	chr5:177366590-177366649	H1-hESC	embryonic stem cell:	n/a	n/a
42	POLR2A	chr5:177366310-177366690	HCT-116	colon:	n/a	n/a
43	POLR2A	chr5:177366175-177366284	HepG2	liver:	n/a	n/a
44	POLR2A	chr5:177366151-177366885	A549	lung:	n/a	n/a
45	POLR2A	chr5:177366774-177366778	Hela-S3	cervix:	n/a	n/a
46	POLR2A	chr5:177366220-177366609	ECC-1	luminal epithelium:	n/a	n/a
47	POLR2A	chr5:177366122-177366921	MCF-7	breast:	n/a	n/a
48	POLR2A	chr5:177366301-177366767	A549	lung:	n/a	n/a
49	POLR2A	chr5:177366193-177366802	A549	lung:	n/a	n/a
50	POLR2A	chr5:177368159-177368197	K562	blood:	n/a	n/a

(count:244 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:177365747-177365797	HCT-116	colon:	n/a
2	chr5:177367013-177367063	MCF-7	breast:	n/a
3	chr5:177367013-177367063	SK-N-SH_RA	brain:	n/a
4	chr5:177366867-177366917	HepG2	liver:	n/a
5	chr5:177366442-177366492	Hela-S3	cervix:	n/a
6	chr5:177366442-177366492	PrEC	prostate:	n/a
7	chr5:177366867-177366917	CMK	blood:	n/a
8	chr5:177366442-177366492	HCT-116	colon:	n/a
9	chr5:177365747-177365797	A549	lung:	n/a
10	chr5:177366867-177366917	HRPEpiC	eye:	n/a
11	chr5:177366442-177366492	HL-60	blood:	n/a
12	chr5:177366442-177366492	NT2-D1	testis:	n/a
13	chr5:177367013-177367063	MCF10A-Er-Src	breast:	n/a
14	chr5:177365747-177365797	NHDF-neo	bronchial:	n/a
15	chr5:177366867-177366917	HCF	heart:	n/a
16	chr5:177366867-177366917	HRCEpiC	kidney:	n/a
17	chr5:177367013-177367063	AG09319	gingival:	n/a
18	chr5:177365747-177365797	SKMC	muscle:	n/a
19	chr5:177365747-177365797	SK-N-MC	brain:	n/a
20	chr5:177366442-177366492	A549	lung:	n/a
21	chr5:177366442-177366492	NHBE	bronchial:	n/a
22	chr5:177365747-177365797	AG09319	gingival:	n/a
23	chr5:177366867-177366917	Hela-S3	cervix:	n/a
24	chr5:177366867-177366917	HUVEC	blood vessel:	n/a
25	chr5:177367013-177367063	HEEpiC	esophagus:	n/a
26	chr5:177365747-177365797	GM12891	blood:	n/a
27	chr5:177365747-177365797	T-47D	breast:	n/a
28	chr5:177365747-177365797	U87	brain:	n/a
29	chr5:177365747-177365797	AoSMC	blood vessel:	n/a
30	chr5:177366867-177366917	HMEC	breast:	n/a
31	chr5:177366867-177366917	Caco-2	colon:	n/a
32	chr5:177366867-177366917	AG10803	skin:	n/a
33	chr5:177365747-177365797	HRPEpiC	eye:	n/a
34	chr5:177366867-177366917	LNCaP	prostate:	n/a
35	chr5:177366867-177366917	NB4	blood:	n/a
36	chr5:177367013-177367063	BE2_C	brain:	n/a
37	chr5:177366867-177366917	T-47D	breast:	n/a
38	chr5:177367013-177367063	HAEpiC	amniotic membrane:	n/a
39	chr5:177366867-177366917	HCPEpiC	choroid plexus:	n/a
40	chr5:177366867-177366917	NHBE	bronchial:	n/a
41	chr5:177366442-177366492	CMK	blood:	n/a
42	chr5:177366442-177366492	AG04450	lung:	fetal
43	chr5:177366867-177366917	HIPEpiC	eye:	n/a
44	chr5:177367013-177367063	Hela-S3	cervix:	n/a
45	chr5:177366867-177366917	GM12891	blood:	n/a
46	chr5:177366867-177366917	HAEpiC	amniotic membrane:	n/a
47	chr5:177366867-177366917	NHDF-neo	bronchial:	n/a
48	chr5:177365747-177365797	HCPEpiC	choroid plexus:	n/a
49	chr5:177366442-177366492	MCF10A-Er-Src	breast:	n/a
50	chr5:177366442-177366492	Caco-2	colon:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr5:175625956..175628511-chr5:177366543..177368721,3	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000250101	TF binding region
ENSG00000250101	CpG island
ENSG00000248596	chromatin interactions

Extended variants
information (count: 107 )
Associated
traits (count: 100 )

Variant overlapped rSNPs/rCNVs (count:107 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs115048620	chr5:177365381-177365382	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs539854008	chr5:177365490-177365491	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs530551702	chr5:177365497-177365498	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs550147909	chr5:177365542-177365543	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs532125542	chr5:177365573-177365574	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs530334558	chr5:177365583-177365584	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs117977479	chr5:177365587-177365588	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs529861823	chr5:177365589-177365590	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs200980829	chr5:177365650-177365651	Weak transcription Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs114834455	chr5:177365696-177365697	Weak transcription Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs566773297	chr5:177365701-177365702	Weak transcription Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs61578169	chr5:177365722-177365723	Weak transcription Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs144960386	chr5:177365727-177365728	Weak transcription Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs547056929	chr5:177365730-177365731	Weak transcription Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs571664074	chr5:177365734-177365735	Weak transcription Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs546840614	chr5:177365742-177365743	Weak transcription Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs539151404	chr5:177365796-177365797	Weak transcription Active TSS Bivalent/Poised TSS Enhancers Bivalent Enhancer	CpG island	1 gene(s)	Overlapped CNVs	n/a
18	rs557190391	chr5:177365808-177365809	Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs569306842	chr5:177365810-177365811	Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs536450920	chr5:177365912-177365913	Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs554703462	chr5:177365935-177365936	Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs573243508	chr5:177365937-177365938	Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs540524073	chr5:177365955-177365956	Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs4958982	chr5:177366001-177366002	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs187322390	chr5:177366002-177366003	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
26	rs193184891	chr5:177366004-177366005	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
27	rs562463339	chr5:177366019-177366020	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
28	rs529746337	chr5:177366051-177366052	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
29	rs542054397	chr5:177366055-177366056	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
30	rs4958983	chr5:177366089-177366090	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs527631865	chr5:177366109-177366110	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs201510536	chr5:177366119-177366120	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs371573742	chr5:177366120-177366121	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs552477946	chr5:177366134-177366135	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs185264991	chr5:177366147-177366148	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs532422827	chr5:177366192-177366193	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs4958984	chr5:177366226-177366227	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs188132639	chr5:177366245-177366246	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs536743474	chr5:177366283-177366284	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs146980538	chr5:177366300-177366301	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs7730399	chr5:177366313-177366314	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs534258574	chr5:177366315-177366316	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs369311858	chr5:177366327-177366328	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs558836206	chr5:177366390-177366391	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs577436139	chr5:177366427-177366428	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs4958985	chr5:177366446-177366447	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
47	rs537448719	chr5:177366448-177366449	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
48	rs556085520	chr5:177366450-177366451	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
49	rs529458408	chr5:177366454-177366455	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
50	rs192730202	chr5:177366521-177366522	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:100)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Glioma	20126413	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Thyroid cancer	19087340	CNVD
Acute myeloid leukemia	20729466	CNVD
lymphocytic leukemia	21291569	CNVD
Multiple myeloma	17550852	CNVD
Salivary gland tumor	18059337	CNVD
Renal cell carcinoma	19377443	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Renal cell carcinoma	18592004	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Prostate cancer	18632612	CNVD
epilepsy	18472482	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Sotos syndrome	21572526	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Sotos syndrome	17561922	CNVD
Sotos syndrome	16773131	CNVD
Mental retardation	16773131	CNVD
Sotos syndrome	22470819	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Acute myeloid leukemia	18000384	CNVD
Sudden cardiac death	19188705	CNVD
Basal cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Olfactory neuroblastoma	18408657	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Lung cancer	17297452	CNVD
Cancer	20164920	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21804112	CNVD
Myelofibrosis	22110671	CNVD
Sotos syndrome	22283845	CNVD
Breast cancer	16272173	CNVD
Sotos syndrome	20503325	CNVD
Lung adenocarcinoma	17086460	CNVD
Congenital Hypertrichosis Syndrome	21636067	CNVD
T-cell acute lymphoblastic leukemia	19406988	CNVD
Breast cancer	19181860	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Ehlers-danlos syndrome	17576883	CNVD
Lung cancer	17086460	CNVD
Autism	19246517	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Ependymoma	20639864	CNVD

Chromatin state (count:217 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:177357400-177365400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
2	chr5:177357800-177365600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
3	chr5:177358000-177365800	Weak transcription	H1 Cell Line	embryonic stem cell
4	chr5:177358000-177365800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
5	chr5:177362000-177365400	Weak transcription	Primary T helper cells fromperipheralblood	blood
6	chr5:177364800-177365600	Weak transcription	Pancreas	Pancrea
7	chr5:177364800-177366200	Enhancers	Primary T cells fromperipheralblood	blood
8	chr5:177365000-177365400	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
9	chr5:177365200-177366000	Enhancers	Primary T helper naive cells fromperipheralblood	blood
10	chr5:177365400-177365600	Bivalent Enhancer	Primary B cells from peripheral blood	blood
11	chr5:177365400-177365800	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
12	chr5:177365400-177365800	Enhancers	Primary T helper cells fromperipheralblood	blood
13	chr5:177365400-177365800	Enhancers	Placenta	Placenta
14	chr5:177365400-177366000	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
15	chr5:177365400-177366200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
16	chr5:177365400-177366200	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
17	chr5:177365400-177366200	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
18	chr5:177365400-177366200	Bivalent Enhancer	Fetal Muscle Leg	muscle
19	chr5:177365600-177365800	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
20	chr5:177365600-177365800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
21	chr5:177365600-177365800	Enhancers	Pancreas	Pancrea
22	chr5:177365600-177366000	Enhancers	Breast Myoepithelial Primary Cells	Breast
23	chr5:177365600-177366000	Enhancers	Primary T regulatory cells fromperipheralblood	blood
24	chr5:177365600-177366000	Enhancers	Primary T killer naive cells fromperipheralblood	blood
25	chr5:177365600-177366000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
26	chr5:177365600-177366000	Bivalent Enhancer	Fetal Brain Female	brain
27	chr5:177365600-177366000	Bivalent Enhancer	Fetal Intestine Small	intestine
28	chr5:177365600-177366200	Enhancers	Primary T helper naive cells from peripheral blood	blood
29	chr5:177365600-177366200	Enhancers	Primary T helper cells PMA-I stimulated	--
30	chr5:177365600-177366200	Bivalent Enhancer	Fetal Stomach	stomach
31	chr5:177365600-177366400	Enhancers	Primary B cells from peripheral blood	blood
32	chr5:177365600-177366800	Active TSS	iPS-15b Cell Line	embryonic stem cell
33	chr5:177365600-177366800	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
34	chr5:177365600-177366800	Enhancers	Primary B cells from cord blood	blood
35	chr5:177365600-177367000	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
36	chr5:177365600-177368200	Active TSS	Pancreatic Islets	Pancreatic Islet
37	chr5:177365800-177366000	Enhancers	H1 Cell Line	embryonic stem cell
38	chr5:177365800-177366000	Enhancers	HUES48 Cell Line	embryonic stem cell
39	chr5:177365800-177366000	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
40	chr5:177365800-177366000	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
41	chr5:177365800-177366000	Enhancers	Rectal Mucosa Donor 31	rectum
42	chr5:177365800-177366200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
43	chr5:177365800-177366200	Active TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
44	chr5:177365800-177366200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
45	chr5:177365800-177366200	Enhancers	Primary T cells from cord blood	blood
46	chr5:177365800-177366200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
47	chr5:177365800-177366200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
48	chr5:177365800-177366200	Enhancers	Liver	Liver
49	chr5:177365800-177366200	Bivalent Enhancer	Fetal Brain Male	brain
50	chr5:177365800-177366200	Bivalent Enhancer	Fetal Muscle Trunk	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links